查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1840581

腎臟病器械市場按產品類型、治療方式和最終用戶分類 - 全球預測（2025-2032 年）

Nephrology Devices Market by Product Type, Modality, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，腎臟病設備市場將成長至 300.4 億美元，複合年成長率為 7.64%。

主要市場統計數據
基準年 2024 166.6億美元
預計年份：2025年 179.3億美元
預測年份：2032年 300.4億美元
複合年成長率 (%) 7.64%

本書權威地介紹了腎臟病醫療器材產業在臨床緊迫性、技術進步、不斷演變的醫療模式和不斷變化的採購重點等背景下的發展現狀。

全球腎臟醫療器材市場正處於臨床需求、技術創新和醫療服務模式轉變的交會點。慢性腎臟病的高發生率、人口老化以及對保護殘餘腎功能的日益重視，持續推動臨床對安全、高效、以患者為中心的醫療服務的需求。同時，感測器技術、數位療法和新型薄膜材料的進步，催生了新一代醫療器械，這些器械強調便攜性、易用性和即時數據整合。這些因素共同作用，正在再形成採購重點和臨床管道，促使醫療服務提供者和支付者重新評估資本配置和服務提供模式。

因此，產業相關人員必須權衡高強度住院治療與居家照護模式發展之間的矛盾。法律規範正在不斷完善，以平衡病人安全與能夠改善療效或減輕醫療負擔的醫療醫療設備的快速護理管道。同時，供應鏈韌性和零件採購日益受到關注，製造商正增加對多元化供應商網路和近岸外包策略的投資。總而言之，這些發展凸顯了一個複雜而又充滿機會的環境：臨床需求、技術能力和系統層面的獎勵正在融合，共同塑造下一波產品開發和商業策略。

探索正在重新定義腎臟病設備的變革性轉變，包括家庭透析治療的興起、人工智慧賦能的醫療服務、基於價值的獎勵以及供應鏈現代化。

過去幾年，腎臟病醫療器材領域發生了翻天覆地的變化，其影響遠不止於產品本身的改進。家庭透析治療已從一種小眾選擇發展成為醫療機構降低系統成本、提升病患生活品質的策略重點，促使廠商設計出更適合非臨床環境的新產品。數位醫療和人工智慧診斷技術也從試點先導計畫走向實際應用，實現了更主動的液體管理、血管通路監測和個人化治療。因此，如今的醫療器材設計不再將軟體、連接性和使用者體驗視為附加功能，而是將其作為核心要求進行整合。

同時，醫保和監管環境鼓勵採用以金額為準的模式，獎勵療效和病患體驗，促使製造商證明其產品具有長期臨床效益並能降低整體醫療成本。供應鏈的轉變和貿易政策的調整正在加速對生產彈性和供應商多元化的投資。新進業者和跨行業聯盟加劇了競爭，醫療設備製造商正與軟體供應商、診斷試劑製造商和醫療服務提供者合作，提供整合解決方案。這些因素共同作用，正在改變腎臟病領域的研發重點、市場推廣模式和長期策略夥伴關係。

評估美國關稅變化於2025年生效後對採購、製造、供應鏈韌性的累積營運和策略影響

美國近期關稅政策的變化以及2025年前的政策調整，對醫療器材採購、零件採購和生產策略都產生了複雜的影響。對於依賴全球採購的聚合物、特殊薄膜和精密零件的醫療器材製造商而言，關稅帶來的成本壓力迫使他們重新評估供應商佈局，並在臨床適用的情況下考慮本地生產或使用替代材料。同時，採購機構和醫院系統也在重新評估其競標方式，以應對進口可能帶來的成本差異，這導致採購週期延長，並更加重視價格調整條款等合約保護措施。

此外，關稅促使企業採取超越短期價格緩解的策略性因應措施。製造商正在加速推進在地化進程，包括與區域委託製造工廠合作，以及對更靠近終端市場的組裝業務進行定向投資。這些措施旨在保護淨利率、維持供應連續性並縮短前置作業時間。值得注意的是，醫療設備組件和製造流程驗證的監管要求意味著，任何採購或組裝的變更都需要周密的臨床和品質規劃，以避免下游流程中斷。因此，儘管關稅會增加成本和營運壓力，但也促使企業重新設計更具韌性的供應鏈，並在採購談判中重新思考自己的價值提案。

透過對產品類型、使用方式和最終用戶的全面細分洞察，明確臨床效用、監管路徑和商業化重點。

在腎臟病醫療器材領域，精細化的市場觀點對於掌握產品開發和商業化重點至關重要。依產品類型分類，市場大致可分為配件、導管、連續性腎臟替代療法 (CRT) 設備、透析設備、血液透析機機和腹膜透析系統。配件包括輸液管路、透析液濃縮液、過濾器和薄膜。導管包括腹膜透析導管和血管通路導管。連續性腎臟替代療法 (CRT) 設備進一步細分為連續性靜脈血液透析設備(CVHD)、連續性靜脈血液血液透析機)和連續性靜脈血液透析設備(CVH)。透析設備依結構分為高通量、低通量和超低通量。血液透析機機分為家用血液透析機、攜帶式血液透析機及固定式血液透析機。這些產品層面的差異會影響監管管道、報銷考量和使用者培訓需求，進而影響產品採用時間和投資重點。

從治療方式的角度來看，連續性腎臟替代療法 (CRT)、血液透析機和腹膜透析之間的差異揭示了它們各自不同的臨床應用領域和推廣促進因素。 CRT 又細分為連續性靜脈血液濾過 (CVH)、連續性靜脈血液透析機)和連續性靜脈血液濾過 (CVH)，這反映了其在加護治療的應用，在這些應用中，精確控制體液和溶質至關重要。血液透析機又細分為居家透析和中心透析，突顯了設備複雜性和使用者人體工學之間的權衡。腹膜透析又分為自動化系統和連續性門診系統，強調了與患者生活方式的融合。最後，將終端使用者細分為門診手術中心、居家醫療機構、醫院和獨立透析中心，顯示不同機構的採購週期、服務模式和臨床人員配備有顯著差異，進而影響售後服務策略和訓練投入。明確細分市場有助於規劃產品藍圖、商業性目標和監管申報。

詳細的區域分析揭示了美洲、歐洲、中東和非洲以及亞太地區的動態如何影響腎臟病器械的監管、商業和推廣策略。

區域動態對腎臟病醫療器材生態系的採納模式、監管預期和競爭地位有顯著影響。在美洲，長期存在的中心透析基礎設施與日益成長的家庭治療和整合式照護路徑需求並存，後者是由醫療機構整合、支付方壓力和病患偏好轉變所驅動的。這種環境有利於那些能夠簡化家庭使用、減輕訓練負擔並與遠端監測平台整合的醫療器材。相較之下，歐洲、中東和非洲地區（EMEA）的管理體制和報銷框架則各不相同。西歐市場通常優先考慮臨床證據和生命週期管理，而中東、非洲和歐洲地區（REMEA）則需要靈活的商業模式和針對性的教育推廣來推動產品普及。這些差異使得各子區域需要採取不同的打入市場策略和監管策略。

同時，亞太市場兼具高銷售機會和價格敏感性，攜帶式和自動化解決方案在居家醫療基礎設施正在發展的城市地區迅速普及。在地化生產能力和區域標準能夠幫助企業根據當地需求客製化產品配置和定價，從而加速產品部署。在任何地區，互通性、臨床培訓和售後服務都是決定市場滲透率和設備長期應用的關鍵因素。因此，區域策略必須在有效利用全球平台的同時，兼顧在地化的監管、經濟和醫療服務實際情況。

公司層面的策略洞察揭示了現有企業、專業供應商和創新新參與企業如何透過夥伴關係、材料和服務模式重塑競爭格局。

腎臟病設備市場的競爭動態由傳統製造商、專業零件供應商以及專注於數位化整合和便攜性的創新新參與企業共同構成​​。歷史悠久的透析設備製造商透過廣泛的服務網路、檢驗的生產流程以及支援其設備安全性的長期臨床數據，持續確保臨床使用者的信賴。同時，專業的透析器和膜製造商正致力於推進材料科學的發展，以改善清除率和生物相容性，這為系統供應商在耗材性能方面實現差異化競爭創造了機會。在創業投資和策略夥伴關係的支持下，新參與企業正大力推動以使用者為中心的設計、遠端監控功能和簡化的維護流程，試圖在家庭和門診市場取代現有企業。

從戰略角度來看，設備原始設備製造商 (OEM)、軟體公司和醫療服務提供者之間的聯盟正變得越來越普遍，這些聯盟提供整合了硬體、分析和護理協調功能的產品。併購、選擇性收購和共同開發契約正被用來加速下一代設備的上市，而對製造靈活性的策略性投資則能夠快速回應區域需求的變化。最終，競爭優勢將越來越不僅取決於設備性能，還取決於提供檢驗的臨床工作流程、響應迅速的服務模式以及對患者報告結果和整體醫療經濟的顯著貢獻的能力。

建議產業領導者採取行動，以增強韌性、加速數位轉型、最佳化採購並有效擴大專用居家醫療設備的應用。

為在不斷發展的腎臟病醫療器材領域取得成功，產業領導者必須採取務實的策略，兼顧短期韌性和長期創新。首先，優先採用模組化產品架構可以加快多種型號的監管申報，縮短本地化配置的調整時間，並能快速應對關稅主導的採購變化。其次，投資於可互通的數位平台，實現遠端監測、預測性維護以及與電子健康記錄的整合，可以使產品脫穎而出，並支援與支付方和醫療服務提供者就基於價值的醫療服務進行討論。第三，應尋求策略供應商多元化和本地組裝能力，以減少對進口產品的依賴，同時確保產品品質和合規性。

此外，製造商應針對居家醫療和非傳統醫療環境開發商業模式，以解決臨床和後勤方面的障礙，例如簡化培訓課程、虛擬入職培訓和配套服務協議。與大型醫療服務提供者網路和支付方開展合作試驗計畫，可以加速產品推廣，同時產生臨床和經濟價值的真實世界證據。最後，企業應積極與監管機構和標準組織合作，為軟體賦能設備和連網耗材製定安全可行的推廣路徑，進而降低核准的不確定性，促進更廣泛的市場接受度。

本報告採用透明的混合方法研究途徑，詳細介紹了主要專家調查、次要證據綜合、檢驗通訊協定和分析框架。

本分析所依據的研究採用了混合方法，結合了結構化的專家訪談和嚴謹的二手證據綜合分析。一手資料包括對臨床負責人、採購負責人、器材工程師和監管專家的深度訪談，以獲取關於推廣障礙、臨床優先事項和籌資策略的第一手觀點。這些見解與二手資料（包括同儕審查的臨床文獻、已發布的監管文件、專利申請和公司披露資訊）進行三角驗證，以檢驗技術聲明和以往的產品發展軌跡。與專家舉行的交叉檢驗研討會解決了分歧，並完善了主題結論。

此分析架構整合了定性洞察、供應鏈圖譜、監管管道分析和產品細分，從而提煉出可執行的見解。在適當情況下，我們運用敏感度分析和情境規劃，考察政策變化（例如關稅調整）可能對策略因應措施的影響。品質保證措施包括透明的調查方法、書面訪談通訊協定以及獨立的專家評審，以確保研究結果的穩健性。這種多層次的方法增強了研究結果的可信度，並提供了從原始資料到策略影響的清晰可追溯性。

最終的綜合分析匯集了臨床趨勢、技術機會、政策阻力以及戰略要務，這些因素將塑造腎臟病醫療器材的未來發展軌跡。

總之，腎臟病醫療器材領域正進入一個以醫療服務分散化、數位化整合需求日益成長以及對供應鏈和政策衝擊更加敏感為特徵的新階段。對更安全、以患者為中心的醫療服務的臨床需求，與為家庭和門診解決方案提供巨大潛力的技術賦能因素相融合。同時，關稅趨勢和區域監管差異要求企業制定靈活的生產和商業化策略，以平衡全球規模和在地化適應性。

展望未來，那些整合模組化產品設計、投資數位生態系統並執行嚴謹的供應鏈多元化策略的企業，將更有利於掌握新的機會。包括製造商、軟體供應商、醫療服務提供者和支付方在內的整個生態系統的策略合作，將加速實證醫學的產生和應用。透過專注於可證實的臨床獲益、簡化的使用者體驗和穩健的營運，相關人員能夠抵禦短期不利因素，同時為腎臟病治療領域的永續創新奠定基礎。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將人工智慧驅動的預測分析技術整合到透析設備中，以最佳化治療方案
  • 開發可攜式家用血液透析機系統
  • 生物工程腎臟支架技術的進步有望實現個人化再生透析治療。
  • 無線連接和行動應用程式在遠端腹膜透析患者監測的應用日益廣泛
  • 引入奈米過濾膜技術以增強透析濾芯的毒素去除能力
  • 腎臟醫療設備製造商與遠端醫療平台擴大虛擬醫療合作

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 腎臟病器材市場（依產品類型分類）

  • 配件
    • 血液輸液管套裝
    • 透析液濃縮液
    • 過濾器和薄膜
  • 導管
    • 腹膜透析導管
    • 血管通路導管
  • 連續性腎臟替代治療裝置
    • 連續性靜脈-靜脈透析設備
    • 連續性血液透析機機
    • 連續性靜脈-靜脈血液濾過裝置
  • 透析設備
    • 高流量透析設備
    • 低流量透析設備
    • 超低流量透析設備
  • 血液透析機機
    • 家用血液透析機機
    • 可攜式血液透析機機
    • 固定式血液透析機機
  • 腹膜透析系統
    • 自動化腹膜透析系統
    • 持續性攜帶式腹膜透析系統

9. 腎臟病器械市場依治療方式分類

  • 連續性腎臟替代療法
    • 連續性靜脈-靜脈血液透析濾過
    • 持續性血液透析機
    • 連續性靜脈-靜脈血液濾過
  • 血液透析機
    • 居家血液透析機
    • 中心血液透析機
  • 腹膜透析
    • 自動化腹膜透析
    • 持續性攜帶式腹膜透析

第10章 腎臟病器械市場（依最終用戶分類）

  • 門診手術中心
  • 居家照護
  • 醫院
  • 獨立透析中心

第11章 腎臟病器械市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章 腎臟病器械市場（按類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 各國腎臟病器材市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Fresenius Medical Care AG & Co. KGaA
    • Baxter International Inc.
    • Nipro Corporation
    • B. Braun Melsungen AG
    • Toray Medical Co. Ltd.
    • Nikkiso Co. Ltd.
    • Asahi Kasei Medical Co. Ltd.
    • Medtronic plc
    • NxStage Medical Inc.
    • JMS Co. Ltd.
Product Code: MRR-030226489D4A

The Nephrology Devices Market is projected to grow by USD 30.04 billion at a CAGR of 7.64% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 16.66 billion
Estimated Year [2025] USD 17.93 billion
Forecast Year [2032] USD 30.04 billion
CAGR (%) 7.64%

Authoritative introduction framing the nephrology devices sector amid clinical urgency, technological advances, evolving care models and shifting procurement priorities

The global nephrology devices arena sits at the intersection of clinical urgency, technological innovation, and shifting care delivery models. Chronic kidney disease prevalence, aging populations, and heightened emphasis on preserving residual renal function continue to drive clinical demand for safe, efficient and patient-centric therapies. At the same time, advances in sensor technologies, digital therapeutics, and novel membrane materials are enabling a new generation of devices that emphasize portability, ease of use and real-time data integration. These combined pressures are reshaping procurement priorities and clinical pathways, prompting providers and payers to reassess capital allocation and service delivery models.

Consequently, industry stakeholders must reconcile the tension between high-acuity inpatient therapies and expanding home-based alternatives. Regulatory frameworks are evolving to balance patient safety with expedited pathways for devices that demonstrably improve outcomes or reduce care burden. Meanwhile, supply chain resilience and component sourcing have gained prominence, with manufacturers increasingly investing in diversified supplier networks and nearshoring strategies. In sum, introduction to this landscape underscores a complex but opportunistic environment in which clinical needs, technological capability and system-level incentives converge to define the next wave of product development and commercial strategy.

Exploring the transformative shifts that are redefining nephrology devices including the rise of home dialysis, AI-enabled care, value-based incentives and supply chain modernization

Over the past several years the nephrology devices landscape has undergone transformative shifts that extend beyond incremental product improvements. Home dialysis adoption is evolving from a niche alternative to a strategic focus for providers seeking to lower system costs and enhance patient quality of life, and this movement is catalyzing new product designs optimized for non-clinical settings. Digital health and AI-enabled diagnostics are moving from pilot projects to operational deployments, enabling more proactive fluid management, vascular access monitoring and therapy personalization. As a result, device design cycles now integrate software, connectivity and user experience as core requirements rather than adjunct features.

At the same time, reimbursement and regulatory environments are encouraging value-based approaches that reward outcomes and patient experience, prompting manufacturers to demonstrate longitudinal clinical benefit and total-cost-of-care impact. Supply chain events and trade policy shifts have accelerated investments in manufacturing flexibility and supplier diversification. New entrants and cross-sector partnerships are increasing competitive intensity, with medical device firms collaborating with software vendors, diagnostics companies and care providers to deliver integrated solutions. These combined shifts are changing the calculus for R&D prioritization, go-to-market models and longer-term strategic alliances within the nephrology sector.

Assessing the cumulative operational and strategic impact of United States tariff changes effective in 2025 on sourcing, manufacturing, procurement and supply chain resilience

Recent tariff developments and policy adjustments in the United States for 2025 have generated a complex set of implications across device procurement, component sourcing and manufacturing strategies. For device makers that depend on globally sourced polymers, specialized membranes and precision components, tariff-related cost pressure has amplified the need to reassess supplier footprints and consider regional manufacturing or alternative materials where clinically appropriate. In parallel, purchasing organizations and hospital systems are re-evaluating tendering practices to incorporate potential import-related cost volatility, leading to longer procurement cycles and increased emphasis on contractual protections such as price adjustment clauses.

Moreover, tariffs have stimulated strategic responses that go beyond immediate price mitigation. Manufacturers are accelerating localization efforts, including partnerships with regional contract manufacturers and targeted investments in assembly operations closer to end markets. These moves are informed by a desire to preserve margin, protect supply continuity and reduce lead times. Importantly, regulatory requirements for device components and manufacturing process validation mean that any shift in sourcing or assembly requires careful clinical and quality planning to avoid downstream disruption. Thus, while tariffs pose cost and operational stress, they are also a catalyst for redesigning resilient supply chains and for rethinking value propositions in procurement discussions.

Comprehensive segmentation insights across product types, modalities and end-user settings that clarify clinical utility, regulatory paths and commercialization priorities

A granular segmentation perspective is critical to navigate product development and commercialization priorities across the nephrology devices spectrum. When dissected by product type, the market encompasses a spectrum ranging from accessories, catheters, continuous renal replacement therapy devices, dialyzers, hemodialysis machines, to peritoneal dialysis systems; accessories include blood tubing sets, dialysate concentrates and filters and membranes; catheters comprise peritoneal dialysis catheters and vascular access catheters; continuous renal replacement therapy devices are further differentiated into continuous venovenous hemodiafiltration, continuous venovenous hemodialysis and continuous venovenous hemofiltration devices; dialyzers vary across high flux, low flux and ultra low flux constructions; hemodialysis machines cover home hemodialysis machines, portable hemodialysis devices and stationary hemodialysis machines; peritoneal dialysis systems are segmented into automated and continuous ambulatory peritoneal dialysis systems. These product-level distinctions drive divergent regulatory pathways, reimbursement considerations and user training requirements that influence time-to-adoption and investment priorities.

Viewed through the modality lens, distinctions among continuous renal replacement therapy, hemodialysis and peritoneal dialysis reveal different clinical niches and adoption drivers; continuous renal replacement therapy subdivisions of continuous venovenous hemodiafiltration, continuous venovenous hemodialysis and continuous venovenous hemofiltration reflect intensive care applications where precision fluid and solute control are paramount, while hemodialysis differentiation between home and in-center use highlights trade-offs between device complexity and user ergonomics, and peritoneal dialysis bifurcation into automated and continuous ambulatory systems underscores patient lifestyle integration considerations. Finally, end-user segmentation across ambulatory surgical centers, home care settings, hospitals and standalone dialysis centers emphasizes that procurement cycles, service models and clinical staffing vary considerably by setting, shaping aftermarket service strategies and training investments. Taken together, segmentation clarity informs product roadmaps, commercial targeting and regulatory dossier planning.

In-depth regional insights showing how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics shape regulatory, commercial and adoption strategies in nephrology devices

Regional dynamics materially influence adoption patterns, regulatory expectations and competitive positioning across the nephrology devices ecosystem. In the Americas, longstanding infrastructure for in-center dialysis coexists with a growing appetite for home therapies and integrated care pathways, driven by provider consolidation, payer pressure and patient preference shifts. This environment favors devices that simplify home use, reduce training burdens and integrate with remote monitoring platforms. In contrast, Europe, Middle East & Africa demonstrates heterogeneous regulatory regimes and reimbursement frameworks; Western European markets often prioritize clinical evidence and lifecycle management while other parts of the region require flexible commercial models and targeted education efforts to accelerate adoption. These disparities necessitate differentiated go-to-market and regulatory strategies across subregions.

Meanwhile, Asia-Pacific markets present a mix of high-volume opportunities and price sensitivity, alongside rapid uptake of portable and automated solutions in urban centers where home care infrastructure is progressing. Local manufacturing capabilities and regional standards can accelerate deployment when companies align product configurations and pricing with local needs. Across all regions, interoperability, clinical training, and after-sales service are decisive factors that determine market penetration and long-term device utilization. Therefore, regional strategies must reconcile global platform efficiencies with local adaptation to regulatory, economic and care delivery realities.

Strategic company-level insights describing how incumbents, specialized suppliers and innovative entrants are reshaping competition through partnerships, materials and service models

Competitive dynamics in nephrology devices are defined by a mix of legacy manufacturers, specialized component producers and innovative newcomers focused on digital integration and portability. Established dialysis equipment manufacturers continue to anchor clinical trust through extensive service networks, validated manufacturing processes and long-term clinical data supporting device safety. At the same time, specialized dialyzer and membrane producers are advancing material science to improve clearance profiles and biocompatibility, creating opportunities for system suppliers to differentiate on consumable performance. New entrants, often backed by venture capital or strategic partnerships, are pushing user-centric designs, remote monitoring capabilities and simplified maintenance profiles to dislodge incumbents in home and ambulatory segments.

Strategically, partnerships between device OEMs, software firms and care providers are becoming more common to deliver integrated offerings that combine hardware with analytics and care coordination. Mergers, selective acquisitions and co-development agreements are being used to accelerate time-to-market for next-generation devices, while strategic investments in manufacturing flexibility enable faster responses to regional demand shifts. Ultimately, competitive advantage will increasingly hinge not only on device performance but on the ability to deliver validated clinical workflows, responsive service models and demonstrable contributions to patient-reported outcomes and overall care economics.

Actionable recommendations for industry leaders to strengthen resilience, accelerate digital transformation, optimize sourcing and scale home-focused device adoption effectively

Industry leaders must adopt pragmatic strategies that balance near-term resilience with long-term innovation to thrive in the evolving nephrology devices sector. First, prioritizing modular product architectures can accelerate regulatory filings across multiple variants and reduce time-to-adapt for localized configurations, enabling faster responses to tariff-driven sourcing changes. Second, investing in interoperable digital platforms that enable remote monitoring, predictive maintenance and integration with electronic health records will differentiate offerings and support value-based care discussions with payers and providers. Third, strategic supplier diversification and localized assembly capabilities should be pursued to mitigate import exposure while ensuring quality and regulatory compliance; these moves should be accompanied by rigorous change control and clinical validation plans.

Additionally, manufacturers should develop tailored commercial models for home care and non-traditional settings, including simplified training curricula, virtual onboarding, and bundled service contracts that address both clinical and logistical barriers to adoption. Collaborative pilot programs with large provider networks and payers can generate pragmatic evidence of clinical and economic value while accelerating adoption. Finally, companies should proactively engage with regulators and standards bodies to shape safe and pragmatic pathways for software-enabled devices and connected consumables, thereby reducing approval uncertainty and fostering wider market acceptance.

Transparent mixed-methods research approach detailing primary expert engagement, secondary evidence synthesis, validation protocols and analytical frameworks used for this report

The research underpinning this analysis employed a mixed-methods approach combining structured primary engagement with subject-matter experts and rigorous secondary evidence synthesis. Primary inputs included in-depth interviews with clinical leaders, procurement officers, device engineers and regulatory specialists to capture firsthand perspectives on adoption barriers, clinical prioritization and sourcing strategies. These insights were triangulated with secondary sources such as peer-reviewed clinical literature, publicly available regulatory documents, patent filings and company disclosures to validate technical claims and historical product trajectories. Cross-validation workshops with domain experts were used to reconcile divergent viewpoints and refine thematic conclusions.

Analytical frameworks integrated qualitative findings with supply chain mapping, regulatory pathway analysis and product segmentation to surface actionable insights. Where appropriate, sensitivity checks and scenario planning were applied to examine how policy shifts, such as tariff adjustments, might influence strategic responses. Quality assurance steps included methodological transparency, documentation of interview protocols, and review cycles with independent experts to ensure robustness. This layered methodology supports the credibility of the findings while providing clear traceability from raw inputs to strategic implications.

Final synthesis connecting clinical trends, technology enablement, policy headwinds and strategic imperatives that will shape the future trajectory of nephrology devices

In conclusion, the nephrology devices landscape is entering a phase defined by greater decentralization of care, intensified expectations for digital integration, and heightened sensitivity to supply chain and policy shocks. Clinical imperatives for safer, more patient-centric therapies are converging with technological enablers to create high-potential pathways for home and ambulatory solutions, while intensive care modalities continue to demand precision and reliability. Concurrently, tariff trajectories and regional regulatory diversity require nimble manufacturing and commercialization strategies that reconcile global scale with local adaptation.

Looking ahead, organizations that integrate modular product design, invest in digital ecosystems, and execute disciplined supply chain diversification will be better positioned to capture emerging opportunities. Strategic collaboration across the ecosystem-including manufacturers, software providers, providers and payers-will accelerate evidence generation and adoption. By focusing on demonstrable clinical benefits, streamlined user experiences, and resilient operations, stakeholders can navigate near-term headwinds while laying the groundwork for sustainable innovation in nephrology care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-driven predictive analytics in dialysis machines to optimize treatment schedules
  • 5.2. Development of portable home hemodialysis systems with automated fluid and electrolyte monitoring
  • 5.3. Advancements in bioengineered kidney scaffolds enabling personalized regenerative dialysis therapies
  • 5.4. Rising use of wireless connectivity and mobile apps for remote peritoneal dialysis patient monitoring
  • 5.5. Implementation of nanofilter membrane technologies to enhance toxin clearance in dialysis cartridges
  • 5.6. Growing partnerships between nephrology device manufacturers and telehealth platforms for virtual care
  • 5.7. Introduction of smart vascular access devices with real-time pressure sensors to prevent fistula failures

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Nephrology Devices Market, by Product Type

  • 8.1. Accessories
    • 8.1.1. Blood Tubing Sets
    • 8.1.2. Dialysate Concentrates
    • 8.1.3. Filters And Membranes
  • 8.2. Catheters
    • 8.2.1. Peritoneal Dialysis Catheters
    • 8.2.2. Vascular Access Catheters
  • 8.3. Continuous Renal Replacement Therapy Devices
    • 8.3.1. Continuous Venovenous Hemodiafiltration Devices
    • 8.3.2. Continuous Venovenous Hemodialysis Devices
    • 8.3.3. Continuous Venovenous Hemofiltration Devices
  • 8.4. Dialyzers
    • 8.4.1. High Flux Dialyzers
    • 8.4.2. Low Flux Dialyzers
    • 8.4.3. Ultra Low Flux Dialyzers
  • 8.5. Hemodialysis Machines
    • 8.5.1. Home Hemodialysis Machine
    • 8.5.2. Portable Hemodialysis Device
    • 8.5.3. Stationary Hemodialysis Machine
  • 8.6. Peritoneal Dialysis Systems
    • 8.6.1. Automated Peritoneal Dialysis Systems
    • 8.6.2. Continuous Ambulatory Peritoneal Dialysis Systems

9. Nephrology Devices Market, by Modality

  • 9.1. Continuous Renal Replacement Therapy
    • 9.1.1. Continuous Venovenous Hemodiafiltration
    • 9.1.2. Continuous Venovenous Hemodialysis
    • 9.1.3. Continuous Venovenous Hemofiltration
  • 9.2. Hemodialysis
    • 9.2.1. Home Hemodialysis
    • 9.2.2. In Center Hemodialysis
  • 9.3. Peritoneal Dialysis
    • 9.3.1. Automated Peritoneal Dialysis
    • 9.3.2. Continuous Ambulatory Peritoneal Dialysis

10. Nephrology Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Home Care Settings
  • 10.3. Hospitals
  • 10.4. Standalone Dialysis Centers

11. Nephrology Devices Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Nephrology Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Nephrology Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Fresenius Medical Care AG & Co. KGaA
    • 14.3.2. Baxter International Inc.
    • 14.3.3. Nipro Corporation
    • 14.3.4. B. Braun Melsungen AG
    • 14.3.5. Toray Medical Co. Ltd.
    • 14.3.6. Nikkiso Co. Ltd.
    • 14.3.7. Asahi Kasei Medical Co. Ltd.
    • 14.3.8. Medtronic plc
    • 14.3.9. NxStage Medical Inc.
    • 14.3.10. JMS Co. Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NEPHROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. NEPHROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NEPHROLOGY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY BLOOD TUBING SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY BLOOD TUBING SETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY BLOOD TUBING SETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY BLOOD TUBING SETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY BLOOD TUBING SETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY BLOOD TUBING SETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYSATE CONCENTRATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYSATE CONCENTRATES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYSATE CONCENTRATES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYSATE CONCENTRATES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYSATE CONCENTRATES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYSATE CONCENTRATES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY FILTERS AND MEMBRANES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY FILTERS AND MEMBRANES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY FILTERS AND MEMBRANES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY FILTERS AND MEMBRANES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY FILTERS AND MEMBRANES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY FILTERS AND MEMBRANES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY VASCULAR ACCESS CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY VASCULAR ACCESS CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY VASCULAR ACCESS CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY VASCULAR ACCESS CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY VASCULAR ACCESS CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY VASCULAR ACCESS CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HIGH FLUX DIALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HIGH FLUX DIALYZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HIGH FLUX DIALYZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HIGH FLUX DIALYZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HIGH FLUX DIALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HIGH FLUX DIALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY LOW FLUX DIALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY LOW FLUX DIALYZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY LOW FLUX DIALYZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY LOW FLUX DIALYZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY LOW FLUX DIALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY LOW FLUX DIALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY ULTRA LOW FLUX DIALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY ULTRA LOW FLUX DIALYZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY ULTRA LOW FLUX DIALYZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY ULTRA LOW FLUX DIALYZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY ULTRA LOW FLUX DIALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY ULTRA LOW FLUX DIALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME HEMODIALYSIS MACHINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME HEMODIALYSIS MACHINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME HEMODIALYSIS MACHINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME HEMODIALYSIS MACHINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME HEMODIALYSIS MACHINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME HEMODIALYSIS MACHINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PORTABLE HEMODIALYSIS DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PORTABLE HEMODIALYSIS DEVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PORTABLE HEMODIALYSIS DEVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PORTABLE HEMODIALYSIS DEVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PORTABLE HEMODIALYSIS DEVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PORTABLE HEMODIALYSIS DEVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY STATIONARY HEMODIALYSIS MACHINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY STATIONARY HEMODIALYSIS MACHINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY STATIONARY HEMODIALYSIS MACHINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY STATIONARY HEMODIALYSIS MACHINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY STATIONARY HEMODIALYSIS MACHINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY STATIONARY HEMODIALYSIS MACHINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIAFILTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMODIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS VENOVENOUS HEMOFILTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME HEMODIALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME HEMODIALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME HEMODIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME HEMODIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME HEMODIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME HEMODIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY IN CENTER HEMODIALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY IN CENTER HEMODIALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY IN CENTER HEMODIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY IN CENTER HEMODIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY IN CENTER HEMODIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY IN CENTER HEMODIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY STANDALONE DIALYSIS CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY STANDALONE DIALYSIS CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY STANDALONE DIALYSIS CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY STANDALONE DIALYSIS CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY STANDALONE DIALYSIS CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY STANDALONE DIALYSIS CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL NEPHROLOGY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS NEPHROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY DIALYZERS, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS MACHINES, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA NEPHROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA NEPHROLOGY DEV